149 related articles for article (PubMed ID: 24787634)
1. [Contribution of PET/CT for the management of hepatosplenic candidiasis in hematology].
Jennane S; Eddou H; Mahtat EM; Konopacki J; Souleau B; Malfuson JV; de Revel T
Med Mal Infect; 2014 Jun; 44(6):281-3. PubMed ID: 24787634
[No Abstract] [Full Text] [Related]
2. Hepatosplenic candidiasis imaged with F-18 FDG PET/CT.
Teyton P; Baillet G; Hindié E; Filmont JE; Sarandi F; Toubert ME; Moretti JL
Clin Nucl Med; 2009 Jul; 34(7):439-40. PubMed ID: 19542950
[No Abstract] [Full Text] [Related]
3. [Hepatosplenic candidiasis in acute myeloid leukemia].
Larregina A; Bartoletti B; Romano H; Paniccia L; Polini NN
Rev Argent Microbiol; 2004; 36(1):28-30. PubMed ID: 15176375
[TBL] [Abstract][Full Text] [Related]
4. Usefulness of positron emission tomography in the differentiation between tumor and infectious lesions in pediatric oncology: a case report.
Tibúrcio FR; de Sá Rodrigues KE; Vasconcelos HM; Miranda DM; Simões e Silva AC
BMC Pediatr; 2015 Sep; 15():108. PubMed ID: 26337867
[TBL] [Abstract][Full Text] [Related]
5. [Favorable Outcome of Hepatosplenic Candidiasis in a Patient with Acute Leukemia].
Čolović N; Arsenijević VA; Suvajdžić N; Djunić I; Tomin D
Srp Arh Celok Lek; 2015; 143(5-6):341-5. PubMed ID: 26259411
[TBL] [Abstract][Full Text] [Related]
6. Hepatosplenic candidiasis after neutropenic phase of acute leukaemia.
Colović M; Lazarević V; Colović R; Janković G; Suvajdzić N; Bogdanović A; Bila J
Med Oncol; 1999 Jul; 16(2):139-42. PubMed ID: 10456663
[TBL] [Abstract][Full Text] [Related]
7. Fluconazole in the treatment of hepatosplenic candidiasis.
Flannery MT; Simmons DB; Saba H; Altus P; Wallach PM; Adelman HM
Arch Intern Med; 1992 Feb; 152(2):406-8. PubMed ID: 1739374
[TBL] [Abstract][Full Text] [Related]
8. [Focal hepato-splenic mycosis caused by Trichosporon beigelii in a patient with acute leukemia].
Alegre A; Algora M; Peñalver MA; Llanos ML; Pérez-Pons C; García Plaza I; Lozano M; Padilla B
Sangre (Barc); 1991 Aug; 36(4):311-4. PubMed ID: 1776110
[TBL] [Abstract][Full Text] [Related]
9. A case of zygomycosis and invasive candidiasis involving the epiglottis and tongue in an immunocompromised patient.
Chemaly RF; Fox SB; Alkotob LM; Scharpf J; Sobecks R; Eliachar I; Procop GW; Smith M; Avery RK; Schmitt SK
Scand J Infect Dis; 2002; 34(2):149-51. PubMed ID: 11928855
[TBL] [Abstract][Full Text] [Related]
10. Typhlitis due to mucormycosis after chemotherapy in a patient with acute myeloid leukemia.
Yi HS; Sym SJ; Park J; Cho EK; Shin DB; Lee JH
Leuk Res; 2010 Jul; 34(7):e173-5. PubMed ID: 20074799
[No Abstract] [Full Text] [Related]
11. Splenic hyalohyphomycosis, molecularly and immunologically consistent with invasive aspergillosis, in a patient with acute lymphoblastic leukemia.
Forghieri F; Rossi G; Potenza L; Morselli M; Barozzi P; Vallerini D; Messino M; Rumpianesi F; Pecorari M; Torelli G; Luppi M
Am J Hematol; 2010 Mar; 85(3):188-9. PubMed ID: 19507207
[No Abstract] [Full Text] [Related]
12. [Focal hepatosplenic candidiasis in patients with cancer].
Martín G; Sanz MA
Enferm Infecc Microbiol Clin; 1990 Mar; 8(3):131-3. PubMed ID: 2094385
[No Abstract] [Full Text] [Related]
13. Double invasive fungal infection and typhlitis in children with acute lymphoblastic leukemia.
Avci Z; Alioglu B; Anuk D; Ozbek OY; Azap OK; Ozbek N
Pediatr Hematol Oncol; 2008 Mar; 25(2):99-106. PubMed ID: 18363175
[TBL] [Abstract][Full Text] [Related]
14. PET/triphasic contrast enhanced CT: Optimized protocol for the assessment of colorectal liver metastases.
Domínguez Ferreras E; García Vicente AM; Cano Cano JM; Molino Trinidad C; Soriano Castrejón AM; Espinosa Arrainz J
Rev Esp Med Nucl Imagen Mol; 2013; 32(5):336-7. PubMed ID: 23583267
[No Abstract] [Full Text] [Related]
15. Chronic systemic (hepatosplenic) candidiasis in a patient with granulocytic sarcoma.
Gangadharan VP; Sasidharan K; Preetha S; Chithrathara K
Am J Clin Oncol; 2000 Dec; 23(6):562-3. PubMed ID: 11202796
[TBL] [Abstract][Full Text] [Related]
16. [Pulmonary aspergillosis in the neutropenic patient. Apropos of 4 cases].
Ben Othman T; Ben Lakhal B; Medini Manai Z; Ladeb S; M'Sadek F; Meddeb B; Ben Abid H; Bel Hadj Ali Z; Hafsia R; Ben Abdeladhim A; Hafsia A
Tunis Med; 1996 Nov; 74(11):493-500. PubMed ID: 9506113
[No Abstract] [Full Text] [Related]
17. Micafungin as primary antifungal prophylaxis in patients presenting with acute myeloid leukemia.
Venton G; Adam H; Colle J; Labiad Y; Mercier C; Ivanov V; Suchon P; Fanciullino R; Farnault L; Costello R
Med Mal Infect; 2016 Jun; 46(4):226-9. PubMed ID: 27126350
[TBL] [Abstract][Full Text] [Related]
18. Hepatosplenic candidiasis in patients with acute leukemia: what is the optimum prophylaxis following subsequent chemotherapy.
Dear A
Eur J Haematol; 1994 Mar; 52(3):184-6. PubMed ID: 8168600
[No Abstract] [Full Text] [Related]
19. Treatment of invasive fungal infections in high risk hematological patients. The outcome with liposomal amphotericin B is not negatively affected by prior administration of mold-active azoles.
De la Serna J; Jarque I; López-Jiménez J; Fernández-Navarro JM; Gómez V; Jurado M; Pascual A; Serrano J; Romero M; Vallejo C
Rev Esp Quimioter; 2013 Mar; 26(1):64-9. PubMed ID: 23546466
[TBL] [Abstract][Full Text] [Related]
20. Zygomycosis in the immunocompromised patient: a case report.
Georgala A; Vekemans M; Husson M; Meuleman N; Beguin H; Nolard N; Aoun M
Acta Biomed; 2006; 77 Suppl 2():5-9. PubMed ID: 16918059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
